Hepatology Communications-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2100864, encodeId=191c210086495, content=请问submit以后，要求提交的CTA and AA forms和LTP forms是啥？是需要每个作者在邮箱确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Wed Nov 16 12:27:24 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221615, encodeId=18c42221615cd, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肝病 经验分享：煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf69428312, createdName=ms7000000465608663, createdTime=Tue Aug 20 23:24:53 CST 2024, time=2024-08-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192545, encodeId=3a441192545cf, content=投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Fri Feb 11 22:54:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235905, encodeId=da4a12359057f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。 转投17天，已经Under review完，速度还可以……accept with revision。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Mon Aug 01 11:31:53 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117466, encodeId=e837211e466df, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审很快，投出后2周左右审稿意见回来，2个Reviewer，最后的审稿意见是reject with opportunity to resubmit，给3个月补实验，1个半月补完重新提交，12天左右文章接收，从接收到proof要1个月，proof要求2天返回，已经过去5天还没有online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b101924754, createdName=LO詹皇VE, createdTime=Sat Mar 04 12:41:26 CST 2023, time=2023-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1116700, encodeId=44061116e00ff, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117368, encodeId=4a1f211e368fc, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿不到一个月给了审稿意见，reject with opportunity to resubmit，提了一点补充样本验证的问题，重新投后很快接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=844e2038968, createdName=1881e93d1em, createdTime=Fri Mar 03 15:12:20 CST 2023, time=2023-03-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096600, encodeId=3af92096600f6, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：hkhkl, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Fri Oct 28 06:25:39 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094716, encodeId=917f2094e16a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：效率还不错。一审一个月，二审1周多一点，accept with revision。这个刊大修貌似就是reject with opportunity to resubmit？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64322411733, createdName=12379bfem31暂无昵称, createdTime=Wed Oct 19 14:00:41 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180952, encodeId=57851180952b7, content=速度比较慢。投了3个月，给了返修意见。现在返修1个月，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Wed Jan 05 17:30:06 CST 2022, time=2022-01-05, status=1, ipAttribution=)]

2022-11-16 ms9000000732799769

请问submit以后，要求提交的CTA and AA forms和LTP forms是啥？是需要每个作者在邮箱确认吗？

99 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2100864, encodeId=191c210086495, content=请问submit以后，要求提交的CTA and AA forms和LTP forms是啥？是需要每个作者在邮箱确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Wed Nov 16 12:27:24 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221615, encodeId=18c42221615cd, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肝病 经验分享：煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf69428312, createdName=ms7000000465608663, createdTime=Tue Aug 20 23:24:53 CST 2024, time=2024-08-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192545, encodeId=3a441192545cf, content=投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Fri Feb 11 22:54:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235905, encodeId=da4a12359057f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。 转投17天，已经Under review完，速度还可以……accept with revision。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Mon Aug 01 11:31:53 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117466, encodeId=e837211e466df, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审很快，投出后2周左右审稿意见回来，2个Reviewer，最后的审稿意见是reject with opportunity to resubmit，给3个月补实验，1个半月补完重新提交，12天左右文章接收，从接收到proof要1个月，proof要求2天返回，已经过去5天还没有online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b101924754, createdName=LO詹皇VE, createdTime=Sat Mar 04 12:41:26 CST 2023, time=2023-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1116700, encodeId=44061116e00ff, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117368, encodeId=4a1f211e368fc, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿不到一个月给了审稿意见，reject with opportunity to resubmit，提了一点补充样本验证的问题，重新投后很快接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=844e2038968, createdName=1881e93d1em, createdTime=Fri Mar 03 15:12:20 CST 2023, time=2023-03-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096600, encodeId=3af92096600f6, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：hkhkl, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Fri Oct 28 06:25:39 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094716, encodeId=917f2094e16a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：效率还不错。一审一个月，二审1周多一点，accept with revision。这个刊大修貌似就是reject with opportunity to resubmit？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64322411733, createdName=12379bfem31暂无昵称, createdTime=Wed Oct 19 14:00:41 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180952, encodeId=57851180952b7, content=速度比较慢。投了3个月，给了返修意见。现在返修1个月，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Wed Jan 05 17:30:06 CST 2022, time=2022-01-05, status=1, ipAttribution=)]

2024-08-20 ms7000000465608663 来自江苏省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肝病
经验分享：煎熬

38 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2100864, encodeId=191c210086495, content=请问submit以后，要求提交的CTA and AA forms和LTP forms是啥？是需要每个作者在邮箱确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Wed Nov 16 12:27:24 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221615, encodeId=18c42221615cd, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肝病 经验分享：煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf69428312, createdName=ms7000000465608663, createdTime=Tue Aug 20 23:24:53 CST 2024, time=2024-08-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192545, encodeId=3a441192545cf, content=投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Fri Feb 11 22:54:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235905, encodeId=da4a12359057f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。 转投17天，已经Under review完，速度还可以……accept with revision。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Mon Aug 01 11:31:53 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117466, encodeId=e837211e466df, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审很快，投出后2周左右审稿意见回来，2个Reviewer，最后的审稿意见是reject with opportunity to resubmit，给3个月补实验，1个半月补完重新提交，12天左右文章接收，从接收到proof要1个月，proof要求2天返回，已经过去5天还没有online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b101924754, createdName=LO詹皇VE, createdTime=Sat Mar 04 12:41:26 CST 2023, time=2023-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1116700, encodeId=44061116e00ff, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117368, encodeId=4a1f211e368fc, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿不到一个月给了审稿意见，reject with opportunity to resubmit，提了一点补充样本验证的问题，重新投后很快接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=844e2038968, createdName=1881e93d1em, createdTime=Fri Mar 03 15:12:20 CST 2023, time=2023-03-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096600, encodeId=3af92096600f6, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：hkhkl, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Fri Oct 28 06:25:39 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094716, encodeId=917f2094e16a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：效率还不错。一审一个月，二审1周多一点，accept with revision。这个刊大修貌似就是reject with opportunity to resubmit？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64322411733, createdName=12379bfem31暂无昵称, createdTime=Wed Oct 19 14:00:41 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180952, encodeId=57851180952b7, content=速度比较慢。投了3个月，给了返修意见。现在返修1个月，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Wed Jan 05 17:30:06 CST 2022, time=2022-01-05, status=1, ipAttribution=)]

2022-02-11 897400411

投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。

104 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2100864, encodeId=191c210086495, content=请问submit以后，要求提交的CTA and AA forms和LTP forms是啥？是需要每个作者在邮箱确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Wed Nov 16 12:27:24 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221615, encodeId=18c42221615cd, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肝病 经验分享：煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf69428312, createdName=ms7000000465608663, createdTime=Tue Aug 20 23:24:53 CST 2024, time=2024-08-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192545, encodeId=3a441192545cf, content=投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Fri Feb 11 22:54:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235905, encodeId=da4a12359057f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。 转投17天，已经Under review完，速度还可以……accept with revision。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Mon Aug 01 11:31:53 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117466, encodeId=e837211e466df, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审很快，投出后2周左右审稿意见回来，2个Reviewer，最后的审稿意见是reject with opportunity to resubmit，给3个月补实验，1个半月补完重新提交，12天左右文章接收，从接收到proof要1个月，proof要求2天返回，已经过去5天还没有online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b101924754, createdName=LO詹皇VE, createdTime=Sat Mar 04 12:41:26 CST 2023, time=2023-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1116700, encodeId=44061116e00ff, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117368, encodeId=4a1f211e368fc, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿不到一个月给了审稿意见，reject with opportunity to resubmit，提了一点补充样本验证的问题，重新投后很快接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=844e2038968, createdName=1881e93d1em, createdTime=Fri Mar 03 15:12:20 CST 2023, time=2023-03-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096600, encodeId=3af92096600f6, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：hkhkl, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Fri Oct 28 06:25:39 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094716, encodeId=917f2094e16a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：效率还不错。一审一个月，二审1周多一点，accept with revision。这个刊大修貌似就是reject with opportunity to resubmit？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64322411733, createdName=12379bfem31暂无昵称, createdTime=Wed Oct 19 14:00:41 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180952, encodeId=57851180952b7, content=速度比较慢。投了3个月，给了返修意见。现在返修1个月，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Wed Jan 05 17:30:06 CST 2022, time=2022-01-05, status=1, ipAttribution=)]

2022-08-01 897400411

审稿速度:1.0 | 投稿命中率:75.0
经验分享：投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。
转投17天，已经Under review完，速度还可以……accept with revision。

161 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2100864, encodeId=191c210086495, content=请问submit以后，要求提交的CTA and AA forms和LTP forms是啥？是需要每个作者在邮箱确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Wed Nov 16 12:27:24 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221615, encodeId=18c42221615cd, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肝病 经验分享：煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf69428312, createdName=ms7000000465608663, createdTime=Tue Aug 20 23:24:53 CST 2024, time=2024-08-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192545, encodeId=3a441192545cf, content=投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Fri Feb 11 22:54:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235905, encodeId=da4a12359057f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。 转投17天，已经Under review完，速度还可以……accept with revision。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Mon Aug 01 11:31:53 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117466, encodeId=e837211e466df, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审很快，投出后2周左右审稿意见回来，2个Reviewer，最后的审稿意见是reject with opportunity to resubmit，给3个月补实验，1个半月补完重新提交，12天左右文章接收，从接收到proof要1个月，proof要求2天返回，已经过去5天还没有online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b101924754, createdName=LO詹皇VE, createdTime=Sat Mar 04 12:41:26 CST 2023, time=2023-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1116700, encodeId=44061116e00ff, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117368, encodeId=4a1f211e368fc, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿不到一个月给了审稿意见，reject with opportunity to resubmit，提了一点补充样本验证的问题，重新投后很快接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=844e2038968, createdName=1881e93d1em, createdTime=Fri Mar 03 15:12:20 CST 2023, time=2023-03-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096600, encodeId=3af92096600f6, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：hkhkl, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Fri Oct 28 06:25:39 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094716, encodeId=917f2094e16a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：效率还不错。一审一个月，二审1周多一点，accept with revision。这个刊大修貌似就是reject with opportunity to resubmit？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64322411733, createdName=12379bfem31暂无昵称, createdTime=Wed Oct 19 14:00:41 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180952, encodeId=57851180952b7, content=速度比较慢。投了3个月，给了返修意见。现在返修1个月，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Wed Jan 05 17:30:06 CST 2022, time=2022-01-05, status=1, ipAttribution=)]

2023-03-04 LO詹皇VE 来自浙江省

审稿速度:1.0 | 投稿命中率:75.0
经验分享：一审很快，投出后2周左右审稿意见回来，2个Reviewer，最后的审稿意见是reject with opportunity to resubmit，给3个月补实验，1个半月补完重新提交，12天左右文章接收，从接收到proof要1个月，proof要求2天返回，已经过去5天还没有online

103 0

[GetPortalCommentsPageByObjectIdResponse(id=2100864, encodeId=191c210086495, content=请问submit以后，要求提交的CTA and AA forms和LTP forms是啥？是需要每个作者在邮箱确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Wed Nov 16 12:27:24 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221615, encodeId=18c42221615cd, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肝病 经验分享：煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf69428312, createdName=ms7000000465608663, createdTime=Tue Aug 20 23:24:53 CST 2024, time=2024-08-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192545, encodeId=3a441192545cf, content=投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Fri Feb 11 22:54:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235905, encodeId=da4a12359057f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。 转投17天，已经Under review完，速度还可以……accept with revision。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Mon Aug 01 11:31:53 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117466, encodeId=e837211e466df, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审很快，投出后2周左右审稿意见回来，2个Reviewer，最后的审稿意见是reject with opportunity to resubmit，给3个月补实验，1个半月补完重新提交，12天左右文章接收，从接收到proof要1个月，proof要求2天返回，已经过去5天还没有online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b101924754, createdName=LO詹皇VE, createdTime=Sat Mar 04 12:41:26 CST 2023, time=2023-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1116700, encodeId=44061116e00ff, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117368, encodeId=4a1f211e368fc, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿不到一个月给了审稿意见，reject with opportunity to resubmit，提了一点补充样本验证的问题，重新投后很快接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=844e2038968, createdName=1881e93d1em, createdTime=Fri Mar 03 15:12:20 CST 2023, time=2023-03-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096600, encodeId=3af92096600f6, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：hkhkl, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Fri Oct 28 06:25:39 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094716, encodeId=917f2094e16a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：效率还不错。一审一个月，二审1周多一点，accept with revision。这个刊大修貌似就是reject with opportunity to resubmit？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64322411733, createdName=12379bfem31暂无昵称, createdTime=Wed Oct 19 14:00:41 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180952, encodeId=57851180952b7, content=速度比较慢。投了3个月，给了返修意见。现在返修1个月，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Wed Jan 05 17:30:06 CST 2022, time=2022-01-05, status=1, ipAttribution=)]

2021-12-28 MS54455111222

引言一般引用多少篇参考文献？

98 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2100864, encodeId=191c210086495, content=请问submit以后，要求提交的CTA and AA forms和LTP forms是啥？是需要每个作者在邮箱确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Wed Nov 16 12:27:24 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221615, encodeId=18c42221615cd, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肝病 经验分享：煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf69428312, createdName=ms7000000465608663, createdTime=Tue Aug 20 23:24:53 CST 2024, time=2024-08-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192545, encodeId=3a441192545cf, content=投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Fri Feb 11 22:54:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235905, encodeId=da4a12359057f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。 转投17天，已经Under review完，速度还可以……accept with revision。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Mon Aug 01 11:31:53 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117466, encodeId=e837211e466df, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审很快，投出后2周左右审稿意见回来，2个Reviewer，最后的审稿意见是reject with opportunity to resubmit，给3个月补实验，1个半月补完重新提交，12天左右文章接收，从接收到proof要1个月，proof要求2天返回，已经过去5天还没有online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b101924754, createdName=LO詹皇VE, createdTime=Sat Mar 04 12:41:26 CST 2023, time=2023-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1116700, encodeId=44061116e00ff, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117368, encodeId=4a1f211e368fc, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿不到一个月给了审稿意见，reject with opportunity to resubmit，提了一点补充样本验证的问题，重新投后很快接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=844e2038968, createdName=1881e93d1em, createdTime=Fri Mar 03 15:12:20 CST 2023, time=2023-03-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096600, encodeId=3af92096600f6, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：hkhkl, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Fri Oct 28 06:25:39 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094716, encodeId=917f2094e16a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：效率还不错。一审一个月，二审1周多一点，accept with revision。这个刊大修貌似就是reject with opportunity to resubmit？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64322411733, createdName=12379bfem31暂无昵称, createdTime=Wed Oct 19 14:00:41 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180952, encodeId=57851180952b7, content=速度比较慢。投了3个月，给了返修意见。现在返修1个月，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Wed Jan 05 17:30:06 CST 2022, time=2022-01-05, status=1, ipAttribution=)]

2023-03-03 1881e93d1em 来自上海

审稿速度:1.0 | 投稿命中率:75.0
经验分享：投稿不到一个月给了审稿意见，reject with opportunity to resubmit，提了一点补充样本验证的问题，重新投后很快接受了。

90 0

[GetPortalCommentsPageByObjectIdResponse(id=2100864, encodeId=191c210086495, content=请问submit以后，要求提交的CTA and AA forms和LTP forms是啥？是需要每个作者在邮箱确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Wed Nov 16 12:27:24 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221615, encodeId=18c42221615cd, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肝病 经验分享：煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf69428312, createdName=ms7000000465608663, createdTime=Tue Aug 20 23:24:53 CST 2024, time=2024-08-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192545, encodeId=3a441192545cf, content=投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Fri Feb 11 22:54:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235905, encodeId=da4a12359057f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。 转投17天，已经Under review完，速度还可以……accept with revision。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Mon Aug 01 11:31:53 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117466, encodeId=e837211e466df, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审很快，投出后2周左右审稿意见回来，2个Reviewer，最后的审稿意见是reject with opportunity to resubmit，给3个月补实验，1个半月补完重新提交，12天左右文章接收，从接收到proof要1个月，proof要求2天返回，已经过去5天还没有online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b101924754, createdName=LO詹皇VE, createdTime=Sat Mar 04 12:41:26 CST 2023, time=2023-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1116700, encodeId=44061116e00ff, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117368, encodeId=4a1f211e368fc, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿不到一个月给了审稿意见，reject with opportunity to resubmit，提了一点补充样本验证的问题，重新投后很快接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=844e2038968, createdName=1881e93d1em, createdTime=Fri Mar 03 15:12:20 CST 2023, time=2023-03-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096600, encodeId=3af92096600f6, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：hkhkl, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Fri Oct 28 06:25:39 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094716, encodeId=917f2094e16a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：效率还不错。一审一个月，二审1周多一点，accept with revision。这个刊大修貌似就是reject with opportunity to resubmit？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64322411733, createdName=12379bfem31暂无昵称, createdTime=Wed Oct 19 14:00:41 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180952, encodeId=57851180952b7, content=速度比较慢。投了3个月，给了返修意见。现在返修1个月，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Wed Jan 05 17:30:06 CST 2022, time=2022-01-05, status=1, ipAttribution=)]

2022-10-28 ms3000000590360295

审稿速度:2.0 | 投稿命中率:25.0
经验分享：hkhkl

100 0

[GetPortalCommentsPageByObjectIdResponse(id=2100864, encodeId=191c210086495, content=请问submit以后，要求提交的CTA and AA forms和LTP forms是啥？是需要每个作者在邮箱确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Wed Nov 16 12:27:24 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221615, encodeId=18c42221615cd, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肝病 经验分享：煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf69428312, createdName=ms7000000465608663, createdTime=Tue Aug 20 23:24:53 CST 2024, time=2024-08-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192545, encodeId=3a441192545cf, content=投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Fri Feb 11 22:54:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235905, encodeId=da4a12359057f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。 转投17天，已经Under review完，速度还可以……accept with revision。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Mon Aug 01 11:31:53 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117466, encodeId=e837211e466df, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审很快，投出后2周左右审稿意见回来，2个Reviewer，最后的审稿意见是reject with opportunity to resubmit，给3个月补实验，1个半月补完重新提交，12天左右文章接收，从接收到proof要1个月，proof要求2天返回，已经过去5天还没有online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b101924754, createdName=LO詹皇VE, createdTime=Sat Mar 04 12:41:26 CST 2023, time=2023-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1116700, encodeId=44061116e00ff, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117368, encodeId=4a1f211e368fc, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿不到一个月给了审稿意见，reject with opportunity to resubmit，提了一点补充样本验证的问题，重新投后很快接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=844e2038968, createdName=1881e93d1em, createdTime=Fri Mar 03 15:12:20 CST 2023, time=2023-03-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096600, encodeId=3af92096600f6, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：hkhkl, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Fri Oct 28 06:25:39 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094716, encodeId=917f2094e16a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：效率还不错。一审一个月，二审1周多一点，accept with revision。这个刊大修貌似就是reject with opportunity to resubmit？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64322411733, createdName=12379bfem31暂无昵称, createdTime=Wed Oct 19 14:00:41 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180952, encodeId=57851180952b7, content=速度比较慢。投了3个月，给了返修意见。现在返修1个月，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Wed Jan 05 17:30:06 CST 2022, time=2022-01-05, status=1, ipAttribution=)]

2022-10-19 12379bfem31暂无昵称

审稿速度:1.0 | 投稿命中率:50.0
经验分享：效率还不错。一审一个月，二审1周多一点，accept with revision。这个刊大修貌似就是reject with opportunity to resubmit？

105 0

[GetPortalCommentsPageByObjectIdResponse(id=2100864, encodeId=191c210086495, content=请问submit以后，要求提交的CTA and AA forms和LTP forms是啥？是需要每个作者在邮箱确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Wed Nov 16 12:27:24 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221615, encodeId=18c42221615cd, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肝病 经验分享：煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf69428312, createdName=ms7000000465608663, createdTime=Tue Aug 20 23:24:53 CST 2024, time=2024-08-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192545, encodeId=3a441192545cf, content=投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Fri Feb 11 22:54:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235905, encodeId=da4a12359057f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投Hepatology，外审2周后给回意见reject，让转投至这个新子刊，IF 5.073……对自己文章知根知底，投其他10分+的很难中，就同意了tranfer，如果能中也是非常好的，祝我好运。 转投17天，已经Under review完，速度还可以……accept with revision。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3ccc4857306, createdName=897400411, createdTime=Mon Aug 01 11:31:53 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117466, encodeId=e837211e466df, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审很快，投出后2周左右审稿意见回来，2个Reviewer，最后的审稿意见是reject with opportunity to resubmit，给3个月补实验，1个半月补完重新提交，12天左右文章接收，从接收到proof要1个月，proof要求2天返回，已经过去5天还没有online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b101924754, createdName=LO詹皇VE, createdTime=Sat Mar 04 12:41:26 CST 2023, time=2023-03-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1116700, encodeId=44061116e00ff, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117368, encodeId=4a1f211e368fc, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿不到一个月给了审稿意见，reject with opportunity to resubmit，提了一点补充样本验证的问题，重新投后很快接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=844e2038968, createdName=1881e93d1em, createdTime=Fri Mar 03 15:12:20 CST 2023, time=2023-03-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096600, encodeId=3af92096600f6, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：hkhkl, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Fri Oct 28 06:25:39 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094716, encodeId=917f2094e16a7, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：效率还不错。一审一个月，二审1周多一点，accept with revision。这个刊大修貌似就是reject with opportunity to resubmit？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=64322411733, createdName=12379bfem31暂无昵称, createdTime=Wed Oct 19 14:00:41 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180952, encodeId=57851180952b7, content=速度比较慢。投了3个月，给了返修意见。现在返修1个月，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Wed Jan 05 17:30:06 CST 2022, time=2022-01-05, status=1, ipAttribution=)]

2022-01-05 ms1000001073912817

速度比较慢。投了3个月，给了返修意见。现在返修1个月，还没消息

191 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务